Notably, its high relevance in the immune response of vertebrates, as well as the involvement in the onset of pathological conditions, e.g., cancer and autoimmune diseases, makes the AhR a promising target for drug development and host-directed therapy (HDT) [7,9,11]. This evidence concerns the gene AHR and autoimmune disease.